Загрузка...
Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys
One consequence of the ongoing opioid epidemic is a large number of overdose deaths. Naloxone reverses opioid-induced respiratory depression; however, its short duration of action limits the protection it can provide. Methocinnamox (MCAM) is a novel opioid receptor antagonist with a long duration of...
Сохранить в:
| Опубликовано в: : | J Pharmacol Exp Ther |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6337004/ https://ncbi.nlm.nih.gov/pubmed/30463875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.118.253286 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|